Clinical Trials Directory

Trials / Unknown

UnknownNCT00773760

MOR and COMT SNP Polymorphism and Pain

Does mu Opioid Receptor (MOR) and Catechol-O-methyltransferase (COMT) Genes Polymorphism Correlate of Clinical Postoperative Pain and Response to Analgesics

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
East Tallinn Central Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients with certain polymorphism in the MOR and COMT genes will display differences in their response to analgesics.

Detailed description

After tissue injury, there is great interindividual variability among patients in the amount of pain experienced (pain intensity and duration of pain) and in the degree of pain relief from analgesics. In experimental settings, Single Nucleotide Polymorphisms (SNP) at the MOR and COMT genes have been found to alter the response to opioids in in vitro models and in human.We will collect clinical data on one hundred patients undergoing surgery. We will obtain DNA extracted via PCR techniques from the patients' blood and we will identify SNPs at the mu opioid receptor and catechol-O-methyltransferase genes. We will analyze the data to search for correlation between clinical patterns of postoperative pain and opioid effects and SNPs.

Conditions

Interventions

TypeNameDescription
OTHERSNP genotypingCoded blood specimens will be transported to the Department of Gene Technology TTÜ and genotyping analysis will be performed. Lymphocytes will be isolated from blood specimens using Ficol-Paq gradients, and genomic DNA isolated using a salting-out procedure. Variants of the MOR gene and other genes of interests will be performed by DNA sequence analysis of PCR-amplified DNA, using primers located in flanking intron sequence. All methods proposed are currently in operation in the respective facilities.

Timeline

Start date
2008-10-01
Primary completion
2009-10-01
Completion
2009-12-01
First posted
2008-10-16
Last updated
2009-08-06

Locations

1 site across 1 country: Estonia

Source: ClinicalTrials.gov record NCT00773760. Inclusion in this directory is not an endorsement.